Earlier this year, a team of Yale researchers showed that the concentration of COVID-19 RNA in sewage mirrors the spread of the disease through a population. In a new study, they find that testing sewage can serve as an early indicator of an outbreak relative to hospitalizations.
Companies often purchase competitors, not to acquire their ideas and products, but to shut them down. A recent report raised questions about whether such an acquisition may be partially responsible for a shortage of ventilators in the United States.
As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.
On March 24, experts in finance, economics, and health from Global Network schools in seven countries gathered for an online conversation about the state of the COVID-19 pandemic, the economic fallout, and the path to recovery.
In a Fortune commentary, Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center, and Yale SOM’s Dr. Howard Forman and Jeffrey Sonnenfeld write that such an approach would be dangerous and ineffective.
Yale SOM’s Saed Alizamir, with Francis de Véricourt of ESMT and Shouqiang Wang of the University of Texas at Dallas, recently published a study that uses game theory to play out the tradeoffs that the WHO and other public agencies face as they try to give timely warnings while maintaining their credibility.
On March 12, a group of public health experts assembled by Yale SOM’s Dr. Howard Forman released a proposal for a set of emergency public health, healthcare, and emergency support measures to respond to the growing COVID-19 outbreak.